Advancing regulatory science for medical countermeasure development :: workshop summary /
Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community a...
Gespeichert in:
| Körperschaften: | , |
|---|---|
| Weitere Verfasser: | , , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
Natlional Academies Press,
©2011.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description |
| Beschreibung: | 1 online resource (xviii, 132 pages) : illustrations |
| Bibliographie: | Includes bibliographical references (pages 81-82). |
| ISBN: | 9780309214919 0309214912 1283253542 9781283253543 9786613253545 6613253545 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn748588094 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 110831s2011 dcua ob 100 0 eng d | ||
| 040 | |a NRC |b eng |e rda |e pn |c NRC |d IDEBK |d N$T |d E7B |d CDX |d ORU |d UMR |d OCLCQ |d YDXCP |d OCLCO |d OCLCQ |d OCLCA |d DKDLA |d OCLCQ |d OCLCO |d OCLCA |d NLGGC |d OCLCA |d OCLCQ |d EBLCP |d DEBSZ |d OCLCQ |d OCLCA |d AZK |d JBG |d LOA |d OCLCO |d VT2 |d OCLCQ |d OCLCO |d TOA |d AGLDB |d MOR |d PIFAG |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d BUF |d OCLCO |d MERER |d CUY |d OCLCQ |d OCLCO |d OCLCF |d STF |d OCLCO |d WRM |d VNS |d OCLCO |d OCLCQ |d VTS |d OCLCO |d COCUF |d NRAMU |d EZ9 |d OCLCQ |d AU@ |d OCLCQ |d WYU |d LVT |d S9I |d REC |d OCLCQ |d DKC |d OCLCO |d OCLCQ |d OCLCO |d M8D |d KIJ |d OCLCQ |d UKAHL |d OCLCQ |d OCLCA |d UKCRE |d BOL |d OCLCO |d OCLCQ |d SFB |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ |d OCLCL | ||
| 016 | 7 | |a 015906292 |2 Uk | |
| 019 | |a 754086593 |a 754329264 |a 758986075 |a 759907748 |a 816861532 |a 819379336 |a 923284117 |a 961513861 |a 962580553 |a 966220061 |a 971081227 |a 988407883 |a 991913269 |a 1021254420 |a 1028786573 |a 1037912119 |a 1038636196 |a 1047524358 |a 1048117325 |a 1055310955 |a 1062936400 |a 1081181109 |a 1114443739 |a 1119522543 |a 1125506672 |a 1153463827 |a 1156326080 |a 1204385074 |a 1204394289 |a 1228562827 |a 1249250282 | ||
| 020 | |a 9780309214919 |q (electronic bk.) | ||
| 020 | |a 0309214912 |q (electronic bk.) | ||
| 020 | |a 1283253542 | ||
| 020 | |a 9781283253543 | ||
| 020 | |a 9786613253545 | ||
| 020 | |a 6613253545 | ||
| 020 | |z 0309214904 | ||
| 020 | |z 9780309214902 | ||
| 024 | 8 | |a 9786613253545 | |
| 035 | |a (OCoLC)748588094 |z (OCoLC)754086593 |z (OCoLC)754329264 |z (OCoLC)758986075 |z (OCoLC)759907748 |z (OCoLC)816861532 |z (OCoLC)819379336 |z (OCoLC)923284117 |z (OCoLC)961513861 |z (OCoLC)962580553 |z (OCoLC)966220061 |z (OCoLC)971081227 |z (OCoLC)988407883 |z (OCoLC)991913269 |z (OCoLC)1021254420 |z (OCoLC)1028786573 |z (OCoLC)1037912119 |z (OCoLC)1038636196 |z (OCoLC)1047524358 |z (OCoLC)1048117325 |z (OCoLC)1055310955 |z (OCoLC)1062936400 |z (OCoLC)1081181109 |z (OCoLC)1114443739 |z (OCoLC)1119522543 |z (OCoLC)1125506672 |z (OCoLC)1153463827 |z (OCoLC)1156326080 |z (OCoLC)1204385074 |z (OCoLC)1204394289 |z (OCoLC)1228562827 |z (OCoLC)1249250282 | ||
| 037 | |a 325354 |b MIL | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RA645.5 |b .A38 2011 ebook | |
| 060 | 4 | |a WX 186 | |
| 072 | 7 | |a HEA |x 033000 |2 bisacsh | |
| 072 | 7 | |a MED |x 003010 |2 bisacsh | |
| 072 | 7 | |a MBP |2 bicssc | |
| 082 | 7 | |a 362.18 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Advancing regulatory science for medical countermeasure development : |b workshop summary / |c Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Forum on Medical and Public Health PreparadnessforCatastropicEvents, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 260 | |a Washington, D.C. : |b Natlional Academies Press, |c ©2011. | ||
| 300 | |a 1 online resource (xviii, 132 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 340 | |g polychrome. |2 rdacc |0 http://rdaregistry.info/termList/RDAColourContent/1003 | ||
| 347 | |a data file | ||
| 504 | |a Includes bibliographical references (pages 81-82). | ||
| 520 | |a Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description | ||
| 505 | 0 | |a Introduction -- MCM enterprise and stakeholder perspectives -- Cutting-edge efforts to advance MCM regulatory science -- MCM regulatory science needs for at-risk populations -- Crosscutting themes and future directions -- Closing remarks. | |
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 610 | 1 | 0 | |a United States. |b Food and Drug Administration |v Congresses. |
| 610 | 1 | 7 | |a United States. |b Food and Drug Administration |2 fast |
| 650 | 0 | |a Emergency management |z United States |x Evaluation |v Congresses. | |
| 650 | 0 | |a Disaster medicine |z United States |x Evaluation |v Congresses. | |
| 650 | 0 | |a Weapons of mass destruction |x Health aspects |v Congresses. | |
| 650 | 0 | |a Chemical agents (Munitions) |v Congresses. | |
| 650 | 1 | 2 | |a Disaster Planning |x organization & administration |0 https://id.nlm.nih.gov/mesh/D004189Q000458 |
| 650 | 1 | 2 | |a Emergency Medical Services |x organization & administration |0 https://id.nlm.nih.gov/mesh/D004632Q000458 |
| 651 | 2 | |a United States |0 https://id.nlm.nih.gov/mesh/D014481 | |
| 650 | 6 | |a Médecine de catastrophes |z États-Unis |x Évaluation |v Congrès. | |
| 650 | 6 | |a Agents chimiques (Munitions) |v Congrès. | |
| 650 | 7 | |a HEALTH & FITNESS |x First Aid. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Allied Health Services |x Emergency Medical Services. |2 bisacsh | |
| 650 | 7 | |a Chemical agents (Munitions) |2 fast | |
| 650 | 7 | |a Emergency management |x Evaluation |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 655 | 2 | |a Congress |0 https://id.nlm.nih.gov/mesh/D016423 | |
| 655 | 4 | |a Electronic resource. | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2014026068 | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Wizemann, Theresa M. | |
| 700 | 1 | |a Altevogt, Bruce M. |0 http://id.loc.gov/authorities/names/n2006181643 | |
| 700 | 1 | |a Claiborne, Anne B. |0 http://id.loc.gov/authorities/names/no2011029945 | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. |0 http://id.loc.gov/authorities/names/no2007051854 | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Medical and Public Health Preparedness for Catastrophic Events. |0 http://id.loc.gov/authorities/names/no2008171927 | |
| 758 | |i has work: |a Advancing regulatory science for medical countermeasure development (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFq66Rm7RQ3K6KP9xGxDpX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Advancing regulatory science for medical countermeasure development. |d Washington, D.C. : Natlional Academies Press, ©2011 |z 9780309214902 |w (OCoLC)744284130 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=396594 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36617411 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36559627 | ||
| 938 | |a Coutts Information Services |b COUT |n 18795009 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378855 | ||
| 938 | |a ebrary |b EBRY |n ebr10495455 | ||
| 938 | |a EBSCOhost |b EBSC |n 396594 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 325354 | ||
| 938 | |a YBP Library Services |b YANK |n 7222085 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn748588094 |
|---|---|
| _version_ | 1816881768897183744 |
| adam_text | |
| any_adam_object | |
| author2 | Wizemann, Theresa M. Altevogt, Bruce M. Claiborne, Anne B. |
| author2_role | |
| author2_variant | t m w tm tmw b m a bm bma a b c ab abc |
| author_GND | http://id.loc.gov/authorities/names/n2006181643 http://id.loc.gov/authorities/names/no2011029945 |
| author_corporate | Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events |
| author_corporate_role | |
| author_facet | Wizemann, Theresa M. Altevogt, Bruce M. Claiborne, Anne B. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events |
| author_sort | Wizemann, Theresa M. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RA645 |
| callnumber-raw | RA645.5 .A38 2011 ebook |
| callnumber-search | RA645.5 .A38 2011 ebook |
| callnumber-sort | RA 3645.5 A38 42011 EBOOK |
| callnumber-subject | RA - Public Medicine |
| collection | ZDB-4-EBA |
| contents | Introduction -- MCM enterprise and stakeholder perspectives -- Cutting-edge efforts to advance MCM regulatory science -- MCM regulatory science needs for at-risk populations -- Crosscutting themes and future directions -- Closing remarks. |
| ctrlnum | (OCoLC)748588094 |
| dewey-full | 362.18 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.18 |
| dewey-search | 362.18 |
| dewey-sort | 3362.18 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08307cam a2200985 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn748588094</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">110831s2011 dcua ob 100 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NRC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">NRC</subfield><subfield code="d">IDEBK</subfield><subfield code="d">N$T</subfield><subfield code="d">E7B</subfield><subfield code="d">CDX</subfield><subfield code="d">ORU</subfield><subfield code="d">UMR</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">DKDLA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">AZK</subfield><subfield code="d">JBG</subfield><subfield code="d">LOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TOA</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MERER</subfield><subfield code="d">CUY</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WRM</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">COCUF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">LVT</subfield><subfield code="d">S9I</subfield><subfield code="d">REC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">M8D</subfield><subfield code="d">KIJ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKCRE</subfield><subfield code="d">BOL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SFB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">015906292</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">754086593</subfield><subfield code="a">754329264</subfield><subfield code="a">758986075</subfield><subfield code="a">759907748</subfield><subfield code="a">816861532</subfield><subfield code="a">819379336</subfield><subfield code="a">923284117</subfield><subfield code="a">961513861</subfield><subfield code="a">962580553</subfield><subfield code="a">966220061</subfield><subfield code="a">971081227</subfield><subfield code="a">988407883</subfield><subfield code="a">991913269</subfield><subfield code="a">1021254420</subfield><subfield code="a">1028786573</subfield><subfield code="a">1037912119</subfield><subfield code="a">1038636196</subfield><subfield code="a">1047524358</subfield><subfield code="a">1048117325</subfield><subfield code="a">1055310955</subfield><subfield code="a">1062936400</subfield><subfield code="a">1081181109</subfield><subfield code="a">1114443739</subfield><subfield code="a">1119522543</subfield><subfield code="a">1125506672</subfield><subfield code="a">1153463827</subfield><subfield code="a">1156326080</subfield><subfield code="a">1204385074</subfield><subfield code="a">1204394289</subfield><subfield code="a">1228562827</subfield><subfield code="a">1249250282</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309214919</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309214912</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283253542</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283253543</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786613253545</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6613253545</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309214904</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309214902</subfield></datafield><datafield tag="024" ind1="8" ind2=" "><subfield code="a">9786613253545</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)748588094</subfield><subfield code="z">(OCoLC)754086593</subfield><subfield code="z">(OCoLC)754329264</subfield><subfield code="z">(OCoLC)758986075</subfield><subfield code="z">(OCoLC)759907748</subfield><subfield code="z">(OCoLC)816861532</subfield><subfield code="z">(OCoLC)819379336</subfield><subfield code="z">(OCoLC)923284117</subfield><subfield code="z">(OCoLC)961513861</subfield><subfield code="z">(OCoLC)962580553</subfield><subfield code="z">(OCoLC)966220061</subfield><subfield code="z">(OCoLC)971081227</subfield><subfield code="z">(OCoLC)988407883</subfield><subfield code="z">(OCoLC)991913269</subfield><subfield code="z">(OCoLC)1021254420</subfield><subfield code="z">(OCoLC)1028786573</subfield><subfield code="z">(OCoLC)1037912119</subfield><subfield code="z">(OCoLC)1038636196</subfield><subfield code="z">(OCoLC)1047524358</subfield><subfield code="z">(OCoLC)1048117325</subfield><subfield code="z">(OCoLC)1055310955</subfield><subfield code="z">(OCoLC)1062936400</subfield><subfield code="z">(OCoLC)1081181109</subfield><subfield code="z">(OCoLC)1114443739</subfield><subfield code="z">(OCoLC)1119522543</subfield><subfield code="z">(OCoLC)1125506672</subfield><subfield code="z">(OCoLC)1153463827</subfield><subfield code="z">(OCoLC)1156326080</subfield><subfield code="z">(OCoLC)1204385074</subfield><subfield code="z">(OCoLC)1204394289</subfield><subfield code="z">(OCoLC)1228562827</subfield><subfield code="z">(OCoLC)1249250282</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">325354</subfield><subfield code="b">MIL</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA645.5</subfield><subfield code="b">.A38 2011 ebook</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WX 186</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">033000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">003010</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MBP</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">362.18</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Advancing regulatory science for medical countermeasure development :</subfield><subfield code="b">workshop summary /</subfield><subfield code="c">Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Forum on Medical and Public Health PreparadnessforCatastropicEvents, Board on Health Sciences Policy, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">Natlional Academies Press,</subfield><subfield code="c">©2011.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xviii, 132 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="340" ind1=" " ind2=" "><subfield code="g">polychrome.</subfield><subfield code="2">rdacc</subfield><subfield code="0">http://rdaregistry.info/termList/RDAColourContent/1003</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 81-82).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Introduction -- MCM enterprise and stakeholder perspectives -- Cutting-edge efforts to advance MCM regulatory science -- MCM regulatory science needs for at-risk populations -- Crosscutting themes and future directions -- Closing remarks.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="610" ind1="1" ind2="0"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="610" ind1="1" ind2="7"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Emergency management</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Disaster medicine</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Weapons of mass destruction</subfield><subfield code="x">Health aspects</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Chemical agents (Munitions)</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Disaster Planning</subfield><subfield code="x">organization & administration</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004189Q000458</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Emergency Medical Services</subfield><subfield code="x">organization & administration</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004632Q000458</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014481</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine de catastrophes</subfield><subfield code="z">États-Unis</subfield><subfield code="x">Évaluation</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Agents chimiques (Munitions)</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">First Aid.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Allied Health Services</subfield><subfield code="x">Emergency Medical Services.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemical agents (Munitions)</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Emergency management</subfield><subfield code="x">Evaluation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Congress</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D016423</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic resource.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">proceedings (reports)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026068</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Actes de congrès.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wizemann, Theresa M.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Altevogt, Bruce M.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2006181643</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claiborne, Anne B.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2011029945</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2007051854</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Medical and Public Health Preparedness for Catastrophic Events.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2008171927</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Advancing regulatory science for medical countermeasure development (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFq66Rm7RQ3K6KP9xGxDpX</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Advancing regulatory science for medical countermeasure development.</subfield><subfield code="d">Washington, D.C. : Natlional Academies Press, ©2011</subfield><subfield code="z">9780309214902</subfield><subfield code="w">(OCoLC)744284130</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=396594</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36617411</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36559627</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">18795009</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3378855</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10495455</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">396594</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">325354</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">7222085</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Congress https://id.nlm.nih.gov/mesh/D016423 Electronic resource. proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf |
| genre_facet | Congress Electronic resource. proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| geographic | United States https://id.nlm.nih.gov/mesh/D014481 United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocn748588094 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:17:58Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/no2007051854 http://id.loc.gov/authorities/names/no2008171927 |
| isbn | 9780309214919 0309214912 1283253542 9781283253543 9786613253545 6613253545 |
| language | English |
| oclc_num | 748588094 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xviii, 132 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Natlional Academies Press, |
| record_format | marc |
| spelling | Advancing regulatory science for medical countermeasure development : workshop summary / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Forum on Medical and Public Health PreparadnessforCatastropicEvents, Board on Health Sciences Policy, Institute of Medicine of the National Academies. Washington, D.C. : Natlional Academies Press, ©2011. 1 online resource (xviii, 132 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier polychrome. rdacc http://rdaregistry.info/termList/RDAColourContent/1003 data file Includes bibliographical references (pages 81-82). Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description Introduction -- MCM enterprise and stakeholder perspectives -- Cutting-edge efforts to advance MCM regulatory science -- MCM regulatory science needs for at-risk populations -- Crosscutting themes and future directions -- Closing remarks. Print version record. English. United States. Food and Drug Administration Congresses. United States. Food and Drug Administration fast Emergency management United States Evaluation Congresses. Disaster medicine United States Evaluation Congresses. Weapons of mass destruction Health aspects Congresses. Chemical agents (Munitions) Congresses. Disaster Planning organization & administration https://id.nlm.nih.gov/mesh/D004189Q000458 Emergency Medical Services organization & administration https://id.nlm.nih.gov/mesh/D004632Q000458 United States https://id.nlm.nih.gov/mesh/D014481 Médecine de catastrophes États-Unis Évaluation Congrès. Agents chimiques (Munitions) Congrès. HEALTH & FITNESS First Aid. bisacsh MEDICAL Allied Health Services Emergency Medical Services. bisacsh Chemical agents (Munitions) fast Emergency management Evaluation fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Congress https://id.nlm.nih.gov/mesh/D016423 Electronic resource. proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf Wizemann, Theresa M. Altevogt, Bruce M. http://id.loc.gov/authorities/names/n2006181643 Claiborne, Anne B. http://id.loc.gov/authorities/names/no2011029945 Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. http://id.loc.gov/authorities/names/no2007051854 Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events. http://id.loc.gov/authorities/names/no2008171927 has work: Advancing regulatory science for medical countermeasure development (Text) https://id.oclc.org/worldcat/entity/E39PCFq66Rm7RQ3K6KP9xGxDpX https://id.oclc.org/worldcat/ontology/hasWork Print version: Advancing regulatory science for medical countermeasure development. Washington, D.C. : Natlional Academies Press, ©2011 9780309214902 (OCoLC)744284130 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=396594 Volltext |
| spellingShingle | Advancing regulatory science for medical countermeasure development : workshop summary / Introduction -- MCM enterprise and stakeholder perspectives -- Cutting-edge efforts to advance MCM regulatory science -- MCM regulatory science needs for at-risk populations -- Crosscutting themes and future directions -- Closing remarks. United States. Food and Drug Administration Congresses. United States. Food and Drug Administration fast Emergency management United States Evaluation Congresses. Disaster medicine United States Evaluation Congresses. Weapons of mass destruction Health aspects Congresses. Chemical agents (Munitions) Congresses. Disaster Planning organization & administration https://id.nlm.nih.gov/mesh/D004189Q000458 Emergency Medical Services organization & administration https://id.nlm.nih.gov/mesh/D004632Q000458 Médecine de catastrophes États-Unis Évaluation Congrès. Agents chimiques (Munitions) Congrès. HEALTH & FITNESS First Aid. bisacsh MEDICAL Allied Health Services Emergency Medical Services. bisacsh Chemical agents (Munitions) fast Emergency management Evaluation fast |
| subject_GND | https://id.nlm.nih.gov/mesh/D004189Q000458 https://id.nlm.nih.gov/mesh/D004632Q000458 https://id.nlm.nih.gov/mesh/D014481 https://id.nlm.nih.gov/mesh/D016423 http://id.loc.gov/authorities/genreForms/gf2014026068 |
| title | Advancing regulatory science for medical countermeasure development : workshop summary / |
| title_auth | Advancing regulatory science for medical countermeasure development : workshop summary / |
| title_exact_search | Advancing regulatory science for medical countermeasure development : workshop summary / |
| title_full | Advancing regulatory science for medical countermeasure development : workshop summary / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Forum on Medical and Public Health PreparadnessforCatastropicEvents, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_fullStr | Advancing regulatory science for medical countermeasure development : workshop summary / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Forum on Medical and Public Health PreparadnessforCatastropicEvents, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_full_unstemmed | Advancing regulatory science for medical countermeasure development : workshop summary / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Forum on Medical and Public Health PreparadnessforCatastropicEvents, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_short | Advancing regulatory science for medical countermeasure development : |
| title_sort | advancing regulatory science for medical countermeasure development workshop summary |
| title_sub | workshop summary / |
| topic | United States. Food and Drug Administration Congresses. United States. Food and Drug Administration fast Emergency management United States Evaluation Congresses. Disaster medicine United States Evaluation Congresses. Weapons of mass destruction Health aspects Congresses. Chemical agents (Munitions) Congresses. Disaster Planning organization & administration https://id.nlm.nih.gov/mesh/D004189Q000458 Emergency Medical Services organization & administration https://id.nlm.nih.gov/mesh/D004632Q000458 Médecine de catastrophes États-Unis Évaluation Congrès. Agents chimiques (Munitions) Congrès. HEALTH & FITNESS First Aid. bisacsh MEDICAL Allied Health Services Emergency Medical Services. bisacsh Chemical agents (Munitions) fast Emergency management Evaluation fast |
| topic_facet | United States. Food and Drug Administration Congresses. United States. Food and Drug Administration Emergency management United States Evaluation Congresses. Disaster medicine United States Evaluation Congresses. Weapons of mass destruction Health aspects Congresses. Chemical agents (Munitions) Congresses. Disaster Planning organization & administration Emergency Medical Services organization & administration United States Médecine de catastrophes États-Unis Évaluation Congrès. Agents chimiques (Munitions) Congrès. HEALTH & FITNESS First Aid. MEDICAL Allied Health Services Emergency Medical Services. Chemical agents (Munitions) Emergency management Evaluation Congress Electronic resource. proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=396594 |
| work_keys_str_mv | AT wizemanntheresam advancingregulatoryscienceformedicalcountermeasuredevelopmentworkshopsummary AT altevogtbrucem advancingregulatoryscienceformedicalcountermeasuredevelopmentworkshopsummary AT claiborneanneb advancingregulatoryscienceformedicalcountermeasuredevelopmentworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation advancingregulatoryscienceformedicalcountermeasuredevelopmentworkshopsummary AT instituteofmedicineusforumonmedicalandpublichealthpreparednessforcatastrophicevents advancingregulatoryscienceformedicalcountermeasuredevelopmentworkshopsummary |